Passive Plus Endocardial Pacing Leads Var. Models
510(k) K932892
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESP | NumberK932892 | Date6 Jul 1994 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESP Substantially Equivalent — Postmarket Surveillance
Overview
AI-generated summary, 18 Sep 2026
The Passive Plus Endocardial Pacing Leads are classified as Permanent Pacemaker Electrodes, designed for endocardial implantation to deliver electrical pacing stimuli to the heart. These leads facilitate cardiac rhythm regulation by transmitting low-energy impulses to the right ventricle or atrium, ensuring proper heart function in patients with bradycardia or conduction disorders.
These leads are supplied sterile and intended for single-use implantation during cardiac procedures. They are regulated under FDA 510(k) clearance (K932892) and fall under the classification of Class 3 medical devices, governed by regulation 870.3680. Multiple model variants are available, each tailored for specific electrode configurations and pacing applications, with postmarket surveillance requirements noted in the submission.
Other devices from Siemens-Pacesetter, Inc.
Questions
AI-generated answers, 18 Sep 2026
Are these pacing leads reusable or intended for single-use only, and how should they be handled before implantation?
These Passive Plus Endocardial Pacing Leads are sterile and intended for single-use only, as explicitly stated in the device description. They must be handled under sterile conditions and used immediately after opening to ensure patient safety and compliance with medical device regulations.
What types of pacing applications are these leads designed for, and where in the heart are they implanted?
These leads are designed for endocardial implantation, meaning they are placed directly inside the heart chambers to deliver pacing stimuli. They are specifically tailored for right ventricular or atrial pacing to regulate cardiac rhythm in patients with bradycardia or conduction disorders, as described in the device’s purpose.
How many model variants are available, and are they differentiated by specific features or electrode configurations?
Multiple model variants exist for these leads, each tailored to specific electrode configurations and pacing applications. While exact distinctions aren’t detailed in the provided data, the 18 listed FEI numbers (e.g., 3002618605, 2183787) suggest a range of designs to accommodate different clinical needs, such as lead length, coil type, or fixation mechanisms.
What regulatory pathway was followed for FDA clearance, and what class does this device fall under?
The Passive Plus Endocardial Pacing Leads were cleared via the traditional 510(k) pathway (K932892) and are classified as Class 3 medical devices under FDA regulation 870.3680. This classification reflects their role in life-sustaining or supporting functions, requiring stringent oversight. The submission was reviewed by the Cardiovascular (CV) Advisory Committee in 1994.